GoodRx and Surescripts Brings Real-Time Drug Discount Pricing in EHRs

GoodRx and Surescripts Brings Real-Time Drug Discount Pricing in EHRs

What You Should Know:

– Today, GoodRx announced an exclusive agreement with health information network Surescripts to deliver real-time drug discount price information for prescriptions in Surescript’ price transparency solution.

– Surescripts is a nationwide network that connects virtually all EHRs, pharmacies and health systems, enabling providers to view patient-specific benefit and cost information and then electronically prescribe a medication. Last year, nearly 2 billion electronic prescriptions were delivered through Surescripts. Integrating GoodRx pricing will support getting cost information into the hands of patients.

Impact of Integration

Approximately one-third of Americans say they have skipped filling a prescription for a chronic condition one or more times because of the cost, according to an internal GoodRx survey.  With this new integration, prescribers using Surescripts Real-Time Prescription Benefit will be able to provide uninsured patients and patients whose price information isn’t already available from their PBM or health plan with drug discount pricing from GoodRx, which provides savings of up to 80% from pharmacy retail prices on prescriptions, so patients can make more educated decisions about their care. Efforts such as these to improve price transparency and help patients make more educated decisions about their care have shown to improve medication adherence.

“Providing prescription price transparency at the point of care is critical to improving medication adherence and ensuring patients can receive the treatment they need,” said Mike Pritts, Chief Product Officer, at Surescripts. “With the addition of our drug discount pricing feature for uninsured patients as well as patients whose price information isn’t already available from their PBM or health plan, Real-Time Prescription Benefit arms prescribers with more of the information they need, so they can have meaningful cost conversations and get patients started on medication they can access and afford.”